Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

11 Mar 2016

Abstract excerpt

Cytogenetic evaluation at the time of diagnosis is essential for risk stratification in multiple myeloma, however little is known about the occurrence and prognostic significance of cytogenetic evolution during follow-up. We studied 989 patients with multiple myeloma, including 304 patients with at least two cytogenetic evaluations. Multivariable-adjusted regression models were used to assess the associations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Monoclonal and Polyclonal Antibodies Research
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26967818
DOI: 10.1038/bcj.2016.15

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myelomaPMID 26967818Read ↗

Interpretation of cytogenetic results in multiple myeloma for clinical practiceSemantic proximity Read ↗

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment responseSemantic proximity Read ↗

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Semantic proximity Read ↗

Evolutionary biology of high-risk multiple myeloma.Semantic proximity Read ↗

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myelomaSemantic proximity Read ↗

Kumar S, Fonseca R, Ketterling RP, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012;119(9):2100-2105.Semantic proximity Read ↗

Cytogenetics helps determine diagnosis and prognosis for multiple myeloma.Semantic proximity Read ↗

Recurrent Cytogenetic Abnormalities in Multiple Myeloma.Semantic proximity Read ↗

Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaSemantic proximity Read ↗

Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myelomaSemantic proximity Read ↗

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.Semantic proximity Read ↗

Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.